Keyphrases
Copolymer
82%
E-selectin
70%
Peptide-polymer Conjugates
56%
Cell-penetrating Peptide
56%
N-(2-hydroxypropyl)methacrylamide Copolymers
49%
Therapeutic Use
41%
Cancer Cells
40%
Diagnostic Applications
39%
HPMA Copolymers
37%
Dendritic Cells
37%
Drug Delivery
36%
Polymer-drug Conjugates
34%
Doxorubicin
33%
Nanomedicine
31%
Doxorubicin Conjugates
30%
Polyion Complex
29%
Polymer Conjugates
28%
Overexpressing
28%
Binding Peptide
26%
Biorecognition
26%
Nanoparticles
25%
Therapeutic Agents
24%
Endothelial Cells
23%
Intracellular Delivery
23%
Anticancer Drugs
23%
Polyethylenimine
22%
Peptide Conjugates
21%
Polyethylene Glycol
21%
IR783
21%
Pro-apoptotic Peptide
20%
Mechanical Strength
20%
Pharmaceutical Carriers
20%
Cargo
20%
Site-specific Delivery
20%
Enteric Coating
19%
Acrylic Polymer
19%
Swelling Properties
19%
Colorectal Cancer
19%
Metastatic Tumor
19%
CD44v
19%
Tumor Microenvironment
19%
Microparticles
18%
Liposomes
18%
Versatile Applications
18%
Colon
18%
Paclitaxel
18%
Therapeutic Efficacy
18%
Small Interfering RNA (siRNA)
18%
Polymer Bound
18%
Drug-free
17%
Pharmacology, Toxicology and Pharmaceutical Science
Copolymer
100%
Malignant Neoplasm
73%
E-Selectin
65%
Neoplasm
56%
Cell Penetrating Peptide
56%
Doxorubicin
55%
N (2 Hydroxypropyl)methacrylamide Copolymer
48%
Drug Conjugate
37%
Nanomedicine
36%
Nanoparticle
28%
Cytotoxicity
27%
Fluorescein Isothiocyanate
27%
Polyacrylic Acid
23%
Enteric Coating
23%
Colorectal Carcinoma
19%
Drug Carrier
19%
Cell Adhesion Proteins
19%
Paclitaxel
18%
Small Interfering RNA
18%
Microparticle
18%
Liposome
18%
Micelle
18%
Receptor
18%
Combination Therapy
18%
Drug Delivery System
17%
Galactose
16%
Anticancer Drug
16%
Tumor Microenvironment
15%
Lactose
14%
Galactoside
14%
Tumor Growth
13%
Colon Adenocarcinoma
13%
Polyethyleneimine
13%
Primary Tumor
12%
Macrogol
12%
Hyaluronic Acid
11%
Complexation
11%
Diseases
10%
Colon Carcinoma
10%
Inflammation
10%
Galectin 3
9%
Controlled Release
9%
Polyanion
9%
Ovary Carcinoma
9%
Selectin (Glycoprotein)
9%
Dexamethasone
9%
Gene Delivery
9%
Heart Ventricle Remodeling
9%
Oligomer
9%
Vasculotropin Receptor 1
9%